Bio Green Med Solution, Inc. (BGMS) - Net Assets
Based on the latest financial reports, Bio Green Med Solution, Inc. (BGMS) has net assets worth $6.84 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($8.19 Million) and total liabilities ($1.34 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Bio Green Med Solution, Inc. liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $6.84 Million |
| % of Total Assets | 83.59% |
| Annual Growth Rate | 2.57% |
| 5-Year Change | -81.85% |
| 10-Year Change | -52.06% |
| Growth Volatility | 315.26 |
Bio Green Med Solution, Inc. - Net Assets Trend (2005–2025)
This chart illustrates how Bio Green Med Solution, Inc.'s net assets have evolved over time, based on quarterly financial data. Also explore Bio Green Med Solution, Inc. balance sheet assets for the complete picture of this company's asset base.
Annual Net Assets for Bio Green Med Solution, Inc. (2005–2025)
The table below shows the annual net assets of Bio Green Med Solution, Inc. from 2005 to 2025. For live valuation and market cap data, see BGMS company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $6.84 Million | +414.72% |
| 2024-12-31 | $-2.17 Million | -458.15% |
| 2023-12-31 | $607.00K | -97.03% |
| 2022-12-31 | $20.43 Million | -45.79% |
| 2021-12-31 | $37.69 Million | +13.33% |
| 2020-12-31 | $33.26 Million | +184.34% |
| 2019-12-31 | $11.70 Million | -23.41% |
| 2018-12-31 | $15.27 Million | -29.84% |
| 2017-12-31 | $21.77 Million | +52.50% |
| 2016-12-31 | $14.27 Million | -24.22% |
| 2015-12-31 | $18.84 Million | -13.15% |
| 2014-12-31 | $21.69 Million | -22.61% |
| 2013-12-31 | $28.02 Million | +179.70% |
| 2012-12-31 | $10.02 Million | -48.62% |
| 2011-12-31 | $19.50 Million | -21.76% |
| 2010-12-31 | $24.92 Million | +436.69% |
| 2009-12-31 | $4.64 Million | -77.50% |
| 2008-12-31 | $20.64 Million | -64.39% |
| 2007-12-31 | $57.97 Million | +7.51% |
| 2006-12-31 | $53.92 Million | +1209.03% |
| 2005-12-31 | $4.12 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Bio Green Med Solution, Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 45441100000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $5.00K | 0.07% |
| Other Comprehensive Income | $-39.00K | -0.57% |
| Other Components | $461.29 Million | 6741.99% |
| Total Equity | $6.84 Million | 100.00% |
Bio Green Med Solution, Inc. Competitors by Market Cap
The table below lists competitors of Bio Green Med Solution, Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Nippon Active Value Fund Plc
LSE:NAVF
|
$5.41 Million |
|
Beyond Air Inc
NASDAQ:XAIR
|
$5.41 Million |
|
Cymat Technologies Ltd.
V:CYM
|
$5.42 Million |
|
Albion Resources Ltd
AU:ALB
|
$5.43 Million |
|
Can Fite Biopharma Ltd
TA:CANF
|
$5.41 Million |
|
Gulf Resources, Inc. (NV) Common Stock
NASDAQ:GURE
|
$5.40 Million |
|
FATHOM NICKEL INC.
F:6Q5
|
$5.40 Million |
|
CARLSON INV. ZY 13
F:2HB
|
$5.40 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bio Green Med Solution, Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -2,174,000 to 6,842,000, a change of 9,016,000.
- Net loss of 2,998,000 reduced equity.
- Dividend payments of 61,000 reduced retained earnings.
- New share issuances of 6,425,000 increased equity.
- Other comprehensive income increased equity by 852,000.
- Other factors increased equity by 4,798,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.00 Million | -43.82% |
| Dividends Paid | $61.00K | -0.89% |
| Share Issuances | $6.42 Million | +93.91% |
| Other Comprehensive Income | $852.00K | +12.45% |
| Other Changes | $4.80 Million | +70.13% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Bio Green Med Solution, Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.31x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.00x to 0.31x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-12-31 | $17619756.84 | $0.98 | x |
| 2008-12-31 | $6107100.59 | $0.98 | x |
| 2009-12-31 | $1265395.10 | $0.98 | x |
| 2010-12-31 | $3981469.65 | $0.98 | x |
| 2011-12-31 | $2343750.00 | $0.98 | x |
| 2012-12-31 | $1043645.83 | $0.98 | x |
| 2013-12-31 | $1597662.49 | $0.98 | x |
| 2014-12-31 | $853522.24 | $0.98 | x |
| 2015-12-31 | $499867.30 | $0.98 | x |
| 2016-12-31 | $300042.04 | $0.98 | x |
| 2017-12-31 | $205359.00 | $0.98 | x |
| 2018-12-31 | $90921.00 | $0.98 | x |
| 2019-12-31 | $51599.10 | $0.98 | x |
| 2020-12-31 | $32962.34 | $0.98 | x |
| 2021-12-31 | $15204.92 | $0.98 | x |
| 2022-12-31 | $6536.47 | $0.98 | x |
| 2023-12-31 | $171.23 | $0.98 | x |
| 2024-12-31 | $-97.43 | $0.98 | x |
| 2025-12-31 | $3.13 | $0.98 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bio Green Med Solution, Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -43.82%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -401.34%
- • Asset Turnover: 0.09x
- • Equity Multiplier: 1.20x
- Recent ROE (-43.82%) is above the historical average (-276.01%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | -438.16% | -5069.66% | 0.02x | 4.63x | $-18.46 Million |
| 2006 | -54.26% | -7560.21% | 0.01x | 1.17x | $-34.65 Million |
| 2007 | -41.49% | -18645.74% | 0.00x | 1.31x | $-29.85 Million |
| 2008 | -195.65% | -4605.02% | 0.03x | 1.50x | $-42.45 Million |
| 2009 | -421.40% | -2148.19% | 0.06x | 3.11x | $-20.03 Million |
| 2010 | -64.28% | -2335.42% | 0.02x | 1.26x | $-18.51 Million |
| 2011 | -78.17% | -2180.69% | 0.03x | 1.33x | $-17.19 Million |
| 2012 | -131.61% | -19110.14% | 0.00x | 1.93x | $-14.19 Million |
| 2013 | -36.23% | -936.62% | 0.03x | 1.27x | $-12.96 Million |
| 2014 | -89.39% | -1118.05% | 0.06x | 1.35x | $-21.56 Million |
| 2015 | -76.15% | -737.76% | 0.08x | 1.31x | $-16.23 Million |
| 2016 | -82.61% | -1398.70% | 0.04x | 1.38x | $-13.22 Million |
| 2017 | -34.32% | 0.00% | 0.00x | 1.19x | $-9.65 Million |
| 2018 | -47.72% | -4858.67% | 0.01x | 1.30x | $-8.82 Million |
| 2019 | -66.94% | 0.00% | 0.00x | 1.31x | $-9.00 Million |
| 2020 | -25.39% | 0.00% | 0.00x | 1.11x | $-11.77 Million |
| 2021 | -48.97% | 0.00% | 0.00x | 1.14x | $-22.23 Million |
| 2022 | -103.74% | 0.00% | 0.00x | 1.37x | $-23.24 Million |
| 2023 | -3715.82% | -5370.24% | 0.05x | 14.51x | $-22.62 Million |
| 2024 | 0.00% | -26074.42% | 0.01x | 0.00x | $-10.99 Million |
| 2025 | -43.82% | -401.34% | 0.09x | 1.20x | $-3.68 Million |
Industry Comparison
This section compares Bio Green Med Solution, Inc.'s net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $44,828,400
- Average return on equity (ROE) among peers: -124.18%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bio Green Med Solution, Inc. (BGMS) | $6.84 Million | -438.16% | 0.20x | $5.41 Million |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-54.64 Million | 0.00% | 0.00x | $118.88 Million |
| Abcellera Biologics Inc (ABCL) | $10.25 Million | -21.57% | 1.29x | $1.07 Billion |
| Abeona Therapeutics Inc (ABEO) | $3.60 Million | -91.89% | 0.28x | $292.09 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $266.97 Million | -19.62% | 0.16x | $171.87 Million |
| Abpro Holdings, Inc. (ABP) | $3.07 Million | -479.81% | 1.57x | $448.19K |
| Absci Corp (ABSI) | $67.00 Million | -21.42% | 0.32x | $345.85 Million |
| Arbutus Biopharma Corp (ABUS) | $88.00 Million | -44.09% | 0.34x | $840.56 Million |
| ABVC Biopharma Inc (ABVC) | $80.00K | -31.70% | 0.38x | $26.41 Million |
| Abivax SA American Depositary Shares (ABVX) | $40.58 Million | -434.26% | 4.06x | $9.33 Billion |
| ACADIA Pharmaceuticals Inc (ACAD) | $23.36 Million | -97.44% | 0.37x | $3.74 Billion |
About Bio Green Med Solution, Inc.
Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It also researches and develops pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. The company was founded in 199… Read more